A 48-week, Randomised, Multi-centre, Openlabelled, Parallel-group Trial to Compare the Efficacy and the Safety of NN304 (Insulin Detemir) and NPH Human Insulin in Subjects With Insulin Requiring Diabetes Mellitus on a Basal-bolus Regimen.
Phase of Trial: Phase III
Latest Information Update: 01 Feb 2017
At a glance
- Drugs Insulin detemir; Insulin suspension isophane
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 23 Jan 2012 Official Title amended as reported by ClinicalTrials.gov.
- 01 Jul 2009 Actual patient number (401) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History